Childhood Cancer

You are here

Juvenile Myelomonocytic Leukemia (JMML)

Juvenile myelomonocytic leukemia (JMML) is a rare type of leukemia that begins from the myeloid cells. It is neither acute (fast-growing) or chronic (slow-growing) and most often occurs in young children (under age 4). 

Latest Juvenile Myelomonocytic Leukemia (JMML) grants

Loren Walensky, MD/PhD , Principal Investigator
Dana-Farber Cancer Institute
Innovation Grants, Awarded 2018
Alan Cantor, MD, PhD, Principal Investigator
Boston Children's Hospital
Innovation Grants, Awarded 2015
Elliot Stieglitz, MD, Principal Investigator
University of California San Francisco
Young Investigator Grants, Awarded 2015

Juvenile Myelomonocytic Leukemia (JMML) Heroes

Latest Juvenile Myelomonocytic Leukemia (JMML) blog posts

When Lilly faced surgery after relapsing, her family made the decision to donate extra tumor tissue to research instead of throwing it away. 

“We hope that Lilly’s neuroblastoma tumor can be some small part of helping other children who... more
Every day, everywhere, children are diagnosed with cancer. Right now, children are in hospitals receiving frontline treatment following a diagnosis. Other children are beginning a clinical trial following a relapse. Still others face long-... more
Last year, we shared the story of 14-year-old Eden Green, who loves to take photos and dance. Eden was in treatment for a form of childhood cancer so rare, that doctors did not have a clinical name for it. After 4 months of treatment on a... more